Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v6-FR
Language French French
Date Updated 2020-09-03 2020-06-04
Drug Identification Number 02247341 02247341
Brand name ACT CIPROFLOXACIN ACT CIPROFLOXACIN
Common or Proper name CIPROFLOXACIN 750MG FC TAB CIPROFLOXACIN 750MG FC TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 750MG 750MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 50 50
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-01 2020-04-01
Estimated end date 2020-09-30 2020-08-31
Actual end date 2020-09-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Allocating to 100% of our market. Allocating to 100% of our market.
Health Canada comments